Entity record
- Operating location
- Hangzhou, Zhejiang
- Province / region
- Zhejiang
- Directory classification
- CDMO
- Manufacturing disclosure
- Publicly disclosed
- Supplier confirmation
- Not supplier-confirmed
- Last directory review
Supplier record / Rank 01
Sinopep-Allsino Biopharmaceutical
94Extensive evidenceProvisional disclosure score
Public profile summary
What the reviewed public record currently shows.
End-to-end CMC development and cGMP manufacturing for peptide and oligonucleotide APIs, from early development through commercial supply.
Sinopep-Allsino Biopharmaceutical is currently classified by this directory as a cdmo associated with Hangzhou, Zhejiang. The capability summary is based on publicly accessible material and has not been confirmed directly by the supplier.
Capability record
Peptide APIscGMPOligonucleotidesCommercial scale
Capabilities summarize reviewed public statements. They do not establish current capacity, regulatory status, product availability, or buyer suitability.
Evidence and sources
One primary source is currently attached.
This record is awaiting additional regulatory, corporate, or independent sources. Absence of a source is not evidence that a certification or capability does not exist.
This is a provisional public-source profile. The supplier has not confirmed this record, and ChinaPeptideSuppliers.com has not audited, certified, tested, or endorsed the company or its products. Submit documented corrections to [email protected].